Aging
Navigate
Back to articleFigure 3(3 of 9)
100%
Figure 3
Figure 3.PLK mutation analysis in GBM (cBioPortal). (A) Frequency of alteration in each query in the detailed cancer types. (B) Overview of genetic alteration per sample in each query gene. (C) Explore clinical sample type comparisons among groups of samples as defined by the query.
Figure 3 — Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastoma | Aging